Search
for
Sort by
Research 30 of 1000+
- Effect of Solvent on Stereoselectivity in Pd/C (Type 39K)-Catalyzed Hydrogenation of Methyl 3-Oxo-4-aza-5-androstene-17-carboxylate, A Key Intermediate for Finasteride and Dutasteride
- Regeneration of Pd/C finasteride synthesis catalyst by extraction-oxidation
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege
- LB1681 Risk of merkel cell carcinoma progression after treatment discontinuation in patients with an objective response to anti-PD-(L)1 immunotherapy
- Predominance of CD27-PD-1- Effector Memory T Cells Re-Expressing CD45RA Characterizes Treatment-Resistant Severe Alopecia Areata
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- Canities Subita after Extreme Trauma Showing Positive Staining for Anti-PD-L1 Antibodies: A New Clue into Etiopathogenesis?
- Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
- Cell Density-Dependent Upregulation of PDCD4 in Keratinocytes and Its Implications for Epidermal Homeostasis and Repair
- Reply to ‘CD123 immunohistochemistry for plasmacytoid dendritic cells is useful in the diagnosis of scarring alopecia’: three PDC-related parameters are useful in differentiating lupus alopecia from LPP
- ODP342 Panhypopituitarism Induced by CTLA-4 and PD-1/PD-L1 Inhibitor Immunotherapy
- Genotypic and Phenotypic Study of PDCD4 gene Concerning micro RNA-21 and micro RNA-449b Polymorphism in Breast Cancer
- Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Tregs: Where We Are and What Comes Next?
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Anti-programmed cell death protein 1-induced lichenoid changes of the nail unit: Histopathologic description
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Reflectance Confocal Microscopy of Adult Periorificial Dermatitis: A Case Report
- ISID1373 - Expression of programmed cell death 1 inversely correlated with the density of CD8+ T cells infiltrating hair follicles in alopecia areata
- 1373 Expression of programmed cell death 1 inversely correlated with the density of CD8+ T cells infiltrating hair follicles in alopecia areata
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Cutaneous lupus erythematosus induced by tislelizumab
- Recurrent inverse necrotizing infundibular crystalline folliculitis
- PD-L1 vNAR promotes hair growth by modulating hair shaft elongation through activating the leptin-STAT3 signaling